PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
Resonance Health Limited (RHT.AX)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISIN

AU000000RHT2

Sector

Healthcare

Highlights

Market Cap

A$27.58M

Total Revenue (TTM)

A$5.32M

Gross Profit (TTM)

A$5.32M

EBITDA (TTM)

A$58.73K

Year Range

A$0.04 - A$0.09

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Performance

Performance Chart

The chart shows the growth of an initial investment of A$10,000 in Resonance Health Limited, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


-40.00%-30.00%-20.00%-10.00%0.00%10.00%20.00%SeptemberOctoberNovemberDecember2025February0
16.45%
RHT.AX (Resonance Health Limited)
Benchmark (^GSPC)

Returns By Period

Resonance Health Limited had a return of 15.38% year-to-date (YTD) and 22.45% in the last 12 months. Over the past 10 years, Resonance Health Limited had an annualized return of 6.80%, while the S&P 500 had an annualized return of 11.21%, indicating that Resonance Health Limited did not perform as well as the benchmark.


RHT.AX

YTD

15.38%

1M

20.00%

6M

0.00%

1Y

22.45%

5Y*

-21.73%

10Y*

6.80%

^GSPC (Benchmark)

YTD

2.90%

1M

3.70%

6M

10.94%

1Y

22.18%

5Y*

12.41%

10Y*

11.21%

*Annualized

Monthly Returns

The table below presents the monthly returns of RHT.AX, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
202513.46%15.38%
2024-8.33%-0.00%27.27%17.14%-21.95%-7.81%-5.08%14.29%-6.25%-20.00%20.83%-10.34%-13.33%
2023-3.33%-10.34%11.54%-24.14%-9.09%5.00%21.43%15.69%33.90%-25.32%3.39%-1.64%0.00%
202210.71%-9.68%-7.14%-7.69%-30.83%-32.53%25.00%-0.00%-20.00%19.64%-10.45%-0.00%-57.14%
2021-18.75%2.56%0.00%-2.50%-0.00%-20.51%6.45%-30.30%-21.74%16.67%-0.00%33.33%-41.67%
2020-15.56%-21.05%-26.67%27.27%28.57%-16.67%3.33%-9.68%17.86%-6.06%3.23%50.00%6.67%
201921.67%4.11%21.05%41.30%-15.38%-4.55%-9.52%15.79%13.64%-0.00%52.00%18.42%275.00%
2018-0.00%13.64%-16.00%9.52%4.35%0.00%-8.33%-0.00%18.18%19.23%-16.13%130.77%172.73%
20177.69%-25.00%9.52%-4.35%-13.64%26.32%4.17%-12.00%-13.64%5.26%35.00%-18.52%-15.38%
2016-4.00%-16.67%-10.00%5.56%10.53%-19.05%47.06%20.00%3.33%-19.35%-0.00%4.00%4.00%
2015-4.88%-7.69%-8.33%18.18%7.69%-0.00%-7.14%-17.95%9.38%-5.71%-18.18%-7.41%-39.02%
201422.15%-7.75%-14.10%-15.42%1.96%-23.08%2.50%46.34%-15.00%-15.69%-2.33%-2.38%-34.19%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of RHT.AX is 58, indicating average performance compared to other stocks on our website. Here’s a breakdown of how it compares using common performance measures.


The Risk-Adjusted Performance Rank of RHT.AX is 5858
Overall Rank
The Sharpe Ratio Rank of RHT.AX is 5555
Sharpe Ratio Rank
The Sortino Ratio Rank of RHT.AX is 6363
Sortino Ratio Rank
The Omega Ratio Rank of RHT.AX is 6262
Omega Ratio Rank
The Calmar Ratio Rank of RHT.AX is 5656
Calmar Ratio Rank
The Martin Ratio Rank of RHT.AX is 5454
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for Resonance Health Limited (RHT.AX) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


Sharpe ratio
The chart of Sharpe ratio for RHT.AX, currently valued at 0.23, compared to the broader market-2.000.002.004.000.231.59
The chart of Sortino ratio for RHT.AX, currently valued at 1.18, compared to the broader market-6.00-4.00-2.000.002.004.001.182.16
The chart of Omega ratio for RHT.AX, currently valued at 1.15, compared to the broader market0.501.001.502.001.151.29
The chart of Calmar ratio for RHT.AX, currently valued at 0.20, compared to the broader market0.002.004.006.000.202.40
The chart of Martin ratio for RHT.AX, currently valued at 0.69, compared to the broader market0.0010.0020.0030.000.699.79
RHT.AX
^GSPC

The current Resonance Health Limited Sharpe ratio is 0.23. This value is calculated based on the past 1 year of trading data and takes into account price changes and dividends.

Use the chart below to compare the Sharpe ratio of Resonance Health Limited with the selected benchmark, providing insights into the investment's historical performance in terms of risk-adjusted returns. Go to the Sharpe ratio tool for more fine-grained control over the calculation options.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.00SeptemberOctoberNovemberDecember2025February
0.23
2.04
RHT.AX (Resonance Health Limited)
Benchmark (^GSPC)

Dividends

Dividend History


Resonance Health Limited doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%SeptemberOctoberNovemberDecember2025February
-98.03%
-1.51%
RHT.AX (Resonance Health Limited)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the Resonance Health Limited. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Resonance Health Limited was 99.77%, occurring on Oct 13, 2008. The portfolio has not yet recovered.

The current Resonance Health Limited drawdown is 98.03%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-99.77%Nov 29, 19963067Oct 13, 2008
-86.36%Apr 29, 1988849Jul 31, 19911282Jun 28, 19962131
-22.44%Jul 31, 19961Jul 31, 199643Sep 30, 199644

Volatility

Volatility Chart

The current Resonance Health Limited volatility is 22.34%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


0.00%10.00%20.00%30.00%40.00%50.00%SeptemberOctoberNovemberDecember2025February
22.34%
3.48%
RHT.AX (Resonance Health Limited)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Resonance Health Limited over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

Annual
Quarterly

0.0

Valuation

The Valuation section provides an assessment of the market value of Resonance Health Limited compared to its peers in the Health Information Services industry.


PE Ratio
100.0200.0300.00.0
The chart displays the price to earnings (P/E) ratio for RHT.AX in comparison to other companies of the Health Information Services industry. Currently, RHT.AX has a PE value of 0.0. This PE value is considered to be low compared to the rest of the industry.
PEG Ratio
0.02.04.06.00.0
The chart displays the price to earnings to growth (PEG) ratio for RHT.AX in comparison to other companies of the Health Information Services industry. Currently, RHT.AX has a PEG value of 0.0. This PEG ratio falls in the average range for the industry.

Historical P/E Ratio Chart

The chart below displays the historical trend of the price-to-earnings (P/E) ratio for Resonance Health Limited.


Loading data...

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab